Drug acetylation in breast cancer
- PMID: 2765373
- PMCID: PMC2247050
- DOI: 10.1038/bjc.1989.260
Drug acetylation in breast cancer
Abstract
The acetylator phenotype was determined in 100 patients with breast cancer and 100 control female subjects using isoniazid. The proportion of fast acetylators in the breast cancer patients (43%) was not significantly different from the control group (43%). We conclude that acetylator phenotype is unlikely to be an important determinant of the risk of developing breast cancer.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
